Skip to main content
. 2021 Jul 15;5(14):2799–2806. doi: 10.1182/bloodadvances.2021004575

Table 1.

Patient characteristics

Total (N = 171)
Age, median (range) 59 (18-85)
Sex, male, n % 120 (70)
Diagnosis, n %
 DLBCL 133 (78)
 Transformed follicular lymphoma 28(16)
 Primary mediastinal B cell lymphoma 10 (6)
IPI score 3-5, n % 96 (56)
 ECOG 0 49 (29)
 >1 Extranodal site 109 (64)
 Disease stages III and IV 140 (82)
Prior chemotherapy lines, n [range] 4 (2-15)
Patients refractory to previous treatment line, n (%) 134 (78)
Previous autologous stem cell transplant, n (%) 45 (26)
Toxicity incidence (first 30 d after treatment), n (%)
CRS grade
 No CRS 11 (6)
 1 79 (46)
 2 67 (39)
 3 6 (4)
 4 8 (5)
ICANS grade
 No CRS 62 (36)
 1 25 (15)
 2 20 (12)
 3 36 (21)
 4 28 (16)